Plus   Neg

WellCare Health Q4 Adj. Profit Beats View; Lifts FY18 Adj. Earnings Outlook

WellCare Health Plans, Inc. (WCG) reported Tuesday that its fourth-quarter net income was $60.7 million or $1.34 per share, significantly higher than last year's $44.9 million or $1.00 per share.

The latest quarter's results include a $56.1 million, or a $1.25 per share, noncash benefit from the revaluation of the company's net deferred tax liability.

However, adjusted net income was $14.2 million or $0.32 per share, compared to $46.0 million or $1.03 per share in the year-ago period.

Total premium revenue for the quarter increased to $4.33 billion from prior year's $3.52 billion. Adjusted premium revenue was $4.30 billion, compared to $3.43 billion a year ago.

On average, analysts polled by Thomson Reuters expected earnings of $0.21 per share on revenues of $4.32 billion for the quarter. Analysts' estimates typically exclude special items.

For fiscal 2018, WellCare raised its outlook for adjusted earnings per share to a range of $9.55 to $9.85 from its previous guidance range of $8.40 to $8.65 per share. Analysts expect earnings of $9.19 per share.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
MillerCoors LLC has filed a lawsuit against Anheuser-Busch Companies LLC, part of Anheuser-Busch InBev, alleging that Anheuser-Busch's ad campaigns associating MillerCoors' products, Miller Lite and Coor Light, with corn syrup is "false and misleading." During the Super Bowl, ABInBev ran an advertising campaign that mocked Miller Lite and Coors Light use corn syrup in brewing. Shares of Biogen Inc. are falling almost 28 percent in Thursday's trading after the company and Japanese drugmaker Eisai Co. said they will discontinue two late-stage trials for their experimental Alzheimer's drug, Aducanumab. The two Phase 3 trials, ENGAGE and EMERGE, are multi-center, randomized, double-blind, placebo-controlled, parallel-group studies designed to evaluate Aducanumab. The European Union on Wednesday ordered Alphabet Inc.'s Google to pay an antitrust fine of 1.49 billion euros for abusing its dominant position in the online search advertising intermediation market by preventing competition. This is the third antitrust fine by the EU against Google and it represents 1.29 percent of the tech giant's turnover in 2018.
Follow RTT